首页 > 最新文献

Revista de gastroenterologia de Mexico (English)最新文献

英文 中文
A comparison of endoscopic procedures performed at a tertiary care hospital before and during the SARS-CoV-2 pandemic 一家三级医院在 SARS-CoV-2 大流行之前和期间进行的内窥镜手术对比。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2023.10.003

Introduction and aim

SARS-CoV-2 emerged in 2019 and had a huge impact on the world. The area of endoscopy suffered great changes, causing a reduction in the number of procedures and its indications. The aim of our study was to compare the quantity, indication, and type of procedures in 2019 with those in 2020.

Method

A retrospective, observational, analytic, and cross-sectional study was conducted, obtaining information from the endoscopy registry. The STROBE checklist was employed.

Statistical analysis

The quantitative variables were analyzed with descriptive statistics (measures of central tendency and dispersion) and the categorical variables with frequencies and percentages. The quantitative variables were compared, using the Student’s t test/Mann–Whitney U test, and the categorical variables with contingency tables, using the Fisher’s exact test.

Results

In 2019, a total of 277 procedures were performed, compared with 139 in 2020. Mean patient age was 98.53 months (61.46 SD) in 2019 and 77.02 months (59.81 SD) in 2020; 352 diagnostic procedures and 136 therapeutic procedures were carried out in 2019, compared with 51 diagnostic procedures and 88 therapeutic procedures in 2020. The number of diagnostic and therapeutic procedures were inverted (72.1%–36.7% and 27.9%–63.3%, respectively) (p < 0.0001). Esophageal varices, upper gastrointestinal bleeding (UGIB), and foreign body extraction were the indications, in order of predominance in 2019, compared with foreign body extraction (p < 0.05), UGIB, and esophageal varices in 2020. There were no differences regarding colonoscopy.

Conclusion

There was a clear difference in indication and type of procedure, with an increase in foreign body extraction in preschoolers.

导言和目的:SARS-CoV-2 于 2019 年出现,对全球产生了巨大影响。内镜领域发生了巨大变化,导致手术数量和适应症减少。我们的研究旨在比较 2019 年与 2020 年的手术数量、适应症和类型:方法:我们从内镜登记处获取信息,开展了一项回顾性、观察性、分析性和横断面研究。统计分析:统计分析:定量变量采用描述性统计(中心倾向和离散度量)进行分析,分类变量采用频率和百分比进行分析。定量变量的比较采用学生 t 检验/曼-惠特尼 U 检验,分类变量的比较采用或然率表,采用费雪精确检验:2019年共进行了277例手术,2020年为139例。2019年患者平均年龄为98.53个月(61.46 SD),2020年为77.02个月(59.81 SD);2019年实施了352项诊断程序和136项治疗程序,2020年实施了51项诊断程序和88项治疗程序。诊断程序和治疗程序的数量倒置(分别为72.1%-36.7%和27.9%-63.3%)(p结论:手术的适应症和类型存在明显差异,学龄前儿童的异物取出术有所增加。
{"title":"A comparison of endoscopic procedures performed at a tertiary care hospital before and during the SARS-CoV-2 pandemic","authors":"","doi":"10.1016/j.rgmxen.2023.10.003","DOIUrl":"10.1016/j.rgmxen.2023.10.003","url":null,"abstract":"<div><h3>Introduction and aim</h3><p>SARS-CoV-2 emerged in 2019 and had a huge impact on the world. The area of endoscopy suffered great changes, causing a reduction in the number of procedures and its indications. The aim of our study was to compare the quantity, indication, and type of procedures in 2019 with those in 2020.</p></div><div><h3>Method</h3><p>A retrospective, observational, analytic, and cross-sectional study was conducted, obtaining information from the endoscopy registry. The STROBE checklist was employed.</p></div><div><h3>Statistical analysis</h3><p>The quantitative variables were analyzed with descriptive statistics (measures of central tendency and dispersion) and the categorical variables with frequencies and percentages. The quantitative variables were compared, using the Student’s t test/Mann–Whitney U test, and the categorical variables with contingency tables, using the Fisher’s exact test.</p></div><div><h3>Results</h3><p>In 2019, a total of 277 procedures were performed, compared with 139 in 2020. Mean patient age was 98.53 months (61.46 SD) in 2019 and 77.02 months (59.81 SD) in 2020; 352 diagnostic procedures and 136 therapeutic procedures were carried out in 2019, compared with 51 diagnostic procedures and 88 therapeutic procedures in 2020. The number of diagnostic and therapeutic procedures were inverted (72.1%–36.7% and 27.9%–63.3%, respectively) (p<!--> <!-->&lt;<!--> <!-->0.0001). Esophageal varices, upper gastrointestinal bleeding (UGIB), and foreign body extraction were the indications, in order of predominance in 2019, compared with foreign body extraction (p<!--> <!-->&lt;<!--> <!-->0.05), UGIB, and esophageal varices in 2020. There were no differences regarding colonoscopy.</p></div><div><h3>Conclusion</h3><p>There was a clear difference in indication and type of procedure, with an increase in foreign body extraction in preschoolers.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 362-368"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000495/pdfft?md5=2cd0609ca8ccd693fa5a853a7e5ade9d&pid=1-s2.0-S2255534X24000495-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new formula proposal for placing pH-impedance catheters in pediatric patients 为儿科患者放置 pH 值阻抗导管的新公式建议。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2023.08.009

Introduction

Esophageal pH-impedance monitoring is a tool for diagnosing gastroesophageal reflux in children. The position of the pH catheter is essential for a reliable reading and the current formulas for calculating catheter insertion length are not completely accurate. The aim of the present study was to develop a new formula for adequate insertion of the pH catheter.

Material and methods

A cross-sectional study was conducted on children that underwent pH-impedance monitoring and later radiographic control, to calculate the correct catheter insertion length. The documented variables were age, sex, weight, height, naris to tragus distance, tragus to sternal notch distance, sternal notch to xiphoid process distance, and initial insertion length determined by the Strobel and height interval formulas. A multivariate regression analysis was carried out to predict the final insertion length. Regression ANOVA and Pearson’s adjusted R-squared tests were performed.

Results

Forty-five pH-impedance studies were carried out, 53% of which were in males. The age and weight variables were not normally distributed. In the initial regression model, the variables that did not significantly correlate with the final insertion length were: sex (P 0.124), length determined by the Strobel or height interval formulas (P 0.078), naris to tragus distance (P 0.905), and tragus to sternal notch distance (P 0.404). The final equation: 5.6 + (height in cm * 0.12) + (sternal notch to xiphoid process distance * 0.57) produced an R2 of 0.93 (P 0.000).

Conclusions

This formula can be considered a valid option for placement of the pH-impedance monitoring catheter in pediatrics.

简介食管 pH 阻抗监测是诊断儿童胃食管反流的一种工具。要获得可靠的读数,pH 导管的位置至关重要,而目前计算导管插入长度的公式并不完全准确。本研究的目的是为适当插入 pH 值导管制定一个新公式:本研究对接受 pH 值阻抗监测的儿童进行了横断面研究,随后进行了放射学检查,以计算导管的正确插入长度。记录的变量包括年龄、性别、体重、身高、窦至窦的距离、窦至胸骨切迹的距离、胸骨切迹至剑突的距离,以及根据 Strobel 和身高间隔公式确定的初始插入长度。为预测最终插入长度,进行了多变量回归分析。进行了回归方差分析和皮尔逊调整 R 方检验:共进行了 45 项 pH 阻抗研究,其中 53% 为男性。年龄和体重变量不呈正态分布。在初始回归模型中,与最终插入长度无显著相关性的变量有:性别(P 0.124)、根据 Strobel 或身高间隔公式确定的长度(P 0.078)、窦至窦的距离(P 0.905)和窦至胸骨切迹的距离(P 0.404)。最终公式为5.6+(身高(厘米)*0.12)+(胸骨切迹到剑突的距离*0.57)得出的 R2 为 0.93(P 0.000):结论:该公式可作为儿科 pH 值阻抗监测导管位置的有效选择。
{"title":"A new formula proposal for placing pH-impedance catheters in pediatric patients","authors":"","doi":"10.1016/j.rgmxen.2023.08.009","DOIUrl":"10.1016/j.rgmxen.2023.08.009","url":null,"abstract":"<div><h3>Introduction</h3><p>Esophageal pH-impedance monitoring is a tool for diagnosing gastroesophageal reflux in children. The position of the pH catheter is essential for a reliable reading and the current formulas for calculating catheter insertion length are not completely accurate. The aim of the present study was to develop a new formula for adequate insertion of the pH catheter.</p></div><div><h3>Material and methods</h3><p>A cross-sectional study was conducted on children that underwent pH-impedance monitoring and later radiographic control, to calculate the correct catheter insertion length. The documented variables were age, sex, weight, height, naris to tragus distance, tragus to sternal notch distance, sternal notch to xiphoid process distance, and initial insertion length determined by the Strobel and height interval formulas. A multivariate regression analysis was carried out to predict the final insertion length. Regression ANOVA and Pearson’s adjusted R-squared tests were performed.</p></div><div><h3>Results</h3><p>Forty-five pH-impedance studies were carried out, 53% of which were in males. The age and weight variables were not normally distributed. In the initial regression model, the variables that did not significantly correlate with the final insertion length were: sex (<em>P</em> 0.124), length determined by the Strobel or height interval formulas (<em>P</em> 0.078), naris to tragus distance (<em>P</em> 0.905), and tragus to sternal notch distance (<em>P</em> 0.404). The final equation: 5.6 + (height in cm * 0.12) + (sternal notch to xiphoid process distance * 0.57) produced an R<sup>2</sup> of 0.93 (<em>P</em> 0.000).</p></div><div><h3>Conclusions</h3><p>This formula can be considered a valid option for placement of the pH-impedance monitoring catheter in pediatrics.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 347-353"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000471/pdfft?md5=38299e837174239f94ece846b65afa9c&pid=1-s2.0-S2255534X24000471-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blundering in high-resolution esophageal manometry in patients with achalasia 贲门失弛缓症患者高分辨率食管测压的误区。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.04.003
{"title":"Blundering in high-resolution esophageal manometry in patients with achalasia","authors":"","doi":"10.1016/j.rgmxen.2024.04.003","DOIUrl":"10.1016/j.rgmxen.2024.04.003","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 444-446"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000550/pdfft?md5=6a8dcec625f5b12d3000e5a4075205c7&pid=1-s2.0-S2255534X24000550-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141437864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Position paper on perioperative management and surgical risk in the patient with cirrhosis 关于肝硬化患者围手术期管理和手术风险的立场文件。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.05.001
J.A. Velarde-Ruiz Velasco , J. Crespo , A. Montaño-Loza , J.M. Aldana-Ledesma , A.D. Cano-Contreras , E. Cerda-Reyes , N.J. Fernández Pérez , G.E. Castro-Narro , E.S. García-Jiménez , J.E. Lira-Vera , Y.I. López-Méndez , J. Meza-Cardona , R. Moreno-Alcántar , J. Pérez-Escobar , J.L. Pérez-Hernández , D.K. Tapia-Calderón , F. Higuera-de-la-Tijera

Introduction

Management of the patient with cirrhosis of the liver that requires surgical treatment has been relatively unexplored. In Mexico, there is currently no formal stance or expert recommendations to guide clinical decision-making in this context.

Aims

The present position paper reviews the existing evidence on risks, prognoses, precautions, special care, and specific management or procedures for patients with cirrhosis that require surgical interventions or invasive procedures. Our aim is to provide recommendations by an expert panel, based on the best published evidence, and consequently ensure timely, quality, efficient, and low-risk care for this specific group of patients.

Results

Twenty-seven recommendations were developed that address preoperative considerations, intraoperative settings, and postoperative follow-up and care.

Conclusions

The assessment and care of patients with cirrhosis that require major surgical or invasive procedures should be overseen by a multidisciplinary team that includes the anesthesiologist, hepatologist, gastroenterologist, and clinical nutritionist. With respect to decompensated patients, a nephrology specialist may be required, given that kidney function is also a parameter involved in the prognosis of these patients.

导言:对需要手术治疗的肝硬化患者的管理相对而言尚未得到研究。目的:本立场文件回顾了关于需要外科手术或侵入性治疗的肝硬化患者的风险、预后、预防措施、特殊护理以及特定管理或程序的现有证据。我们的目的是由专家小组根据已发表的最佳证据提出建议,从而确保为这一特殊群体的患者提供及时、优质、高效和低风险的护理:结果:共提出了 27 项建议,涉及术前注意事项、术中设置以及术后随访和护理:结论:需要进行大型手术或侵入性治疗的肝硬化患者的评估和护理应由多学科团队负责,包括麻醉师、肝病专家、肠胃病专家和临床营养师。对于失代偿期患者,可能需要肾脏病专家,因为肾功能也是影响这些患者预后的一个参数。
{"title":"Position paper on perioperative management and surgical risk in the patient with cirrhosis","authors":"J.A. Velarde-Ruiz Velasco ,&nbsp;J. Crespo ,&nbsp;A. Montaño-Loza ,&nbsp;J.M. Aldana-Ledesma ,&nbsp;A.D. Cano-Contreras ,&nbsp;E. Cerda-Reyes ,&nbsp;N.J. Fernández Pérez ,&nbsp;G.E. Castro-Narro ,&nbsp;E.S. García-Jiménez ,&nbsp;J.E. Lira-Vera ,&nbsp;Y.I. López-Méndez ,&nbsp;J. Meza-Cardona ,&nbsp;R. Moreno-Alcántar ,&nbsp;J. Pérez-Escobar ,&nbsp;J.L. Pérez-Hernández ,&nbsp;D.K. Tapia-Calderón ,&nbsp;F. Higuera-de-la-Tijera","doi":"10.1016/j.rgmxen.2024.05.001","DOIUrl":"10.1016/j.rgmxen.2024.05.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Management of the patient with cirrhosis of the liver that requires surgical treatment has been relatively unexplored. In Mexico, there is currently no formal stance or expert recommendations to guide clinical decision-making in this context.</p></div><div><h3>Aims</h3><p>The present position paper reviews the existing evidence on risks, prognoses, precautions, special care, and specific management or procedures for patients with cirrhosis that require surgical interventions or invasive procedures. Our aim is to provide recommendations by an expert panel, based on the best published evidence, and consequently ensure timely, quality, efficient, and low-risk care for this specific group of patients.</p></div><div><h3>Results</h3><p>Twenty-seven recommendations were developed that address preoperative considerations, intraoperative settings, and postoperative follow-up and care.</p></div><div><h3>Conclusions</h3><p>The assessment and care of patients with cirrhosis that require major surgical or invasive procedures should be overseen by a multidisciplinary team that includes the anesthesiologist, hepatologist, gastroenterologist, and clinical nutritionist. With respect to decompensated patients, a nephrology specialist may be required, given that kidney function is also a parameter involved in the prognosis of these patients.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 418-441"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000574/pdfft?md5=5cee550d2160a3852de6a2d958dc232b&pid=1-s2.0-S2255534X24000574-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141604607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival analysis of the surgical treatment of hepatocellular carcinoma at a tertiary care center 一家三级医疗中心肝细胞癌手术治疗的存活率分析。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2022.12.001

Introduction and aims

Hepatocellular carcinoma (HCC) is a primary malignant tumor of liver epithelial cells and is the most frequent primary liver cancer. The broadening of transplantation and resectability criteria has made therapeutic decisions more complex. Our aim was to describe the clinical and survival characteristics of patients with HCC treated through resection or liver transplantation at our hospital and identify the presence of factors that enable outcome prediction and facilitate therapeutic decision-making.

Materials and methods

Patients with HCC that underwent surgery with curative intent at the Hospital Universitario Marqués de Valdecilla, within the time frame of 2007 and 2017, were retrospectively identified. Survival, mortality, disease-free interval, and different outcome-related variables were analyzed.

Results

Ninety-six patients with a mean follow-up after surgery of 44 months were included. Overall mortality and recurrence were higher in the resection group. Mean survival was 51.4 months in the liver transplantation group and 37.5 months in the resection group, and the disease-free interval was 49.4 ± 37.2 and 27.4 ± 28.7 months, respectively (p = 0.002). The tumor burden score was statistically significant regarding risk for recurrence and specific mortality.

Conclusions

There appears to be no patient subgroup in whom the results of surgical resection were superior or comparable to those of transplantation. Tumor burden determination could be a useful tool for patient subclassification and help guide therapeutic decision-making.

导言和目的:肝细胞癌(HCC)是肝上皮细胞的原发性恶性肿瘤,也是最常见的原发性肝癌。移植和可切除标准的扩大使治疗决策变得更加复杂。我们的目的是描述本院通过切除术或肝移植治疗的 HCC 患者的临床和生存特征,并确定是否存在可预测结果和促进治疗决策的因素:对2007年至2017年期间在巴尔德西亚侯爵大学医院(Hospital Universitario Marqués de Valdecilla)接受治愈性手术的HCC患者进行了回顾性鉴定。分析了患者的生存率、死亡率、无病间隔期以及不同的结果相关变量:共纳入96名患者,术后平均随访44个月。切除组的总死亡率和复发率较高。肝移植组的平均生存期为 51.4 个月,切除组为 37.5 个月,无病间隔时间分别为 49.4 ± 37.2 个月和 27.4 ± 28.7 个月(P = 0.002)。肿瘤负荷评分对复发风险和特定死亡率有统计学意义:结论:似乎没有哪个亚组患者的手术切除效果优于或类似于移植手术。肿瘤负荷测定可作为患者亚分类的有用工具,并有助于指导治疗决策。
{"title":"Survival analysis of the surgical treatment of hepatocellular carcinoma at a tertiary care center","authors":"","doi":"10.1016/j.rgmxen.2022.12.001","DOIUrl":"10.1016/j.rgmxen.2022.12.001","url":null,"abstract":"<div><h3>Introduction and aims</h3><p>Hepatocellular carcinoma (HCC) is a primary malignant tumor of liver epithelial cells and is the most frequent primary liver cancer. The broadening of transplantation and resectability criteria has made therapeutic decisions more complex. Our aim was to describe the clinical and survival characteristics of patients with HCC treated through resection or liver transplantation at our hospital and identify the presence of factors that enable outcome prediction and facilitate therapeutic decision-making.</p></div><div><h3>Materials and methods</h3><p>Patients with HCC that underwent surgery with curative intent at the <em>Hospital Universitario Marqués de Valdecilla</em>, within the time frame of 2007 and 2017, were retrospectively identified. Survival, mortality, disease-free interval, and different outcome-related variables were analyzed.</p></div><div><h3>Results</h3><p>Ninety-six patients with a mean follow-up after surgery of 44 months were included. Overall mortality and recurrence were higher in the resection group. Mean survival was 51.4 months in the liver transplantation group and 37.5 months in the resection group, and the disease-free interval was 49.4 ± 37.2 and 27.4 ± 28.7 months, respectively (p = 0.002). The tumor burden score was statistically significant regarding risk for recurrence and specific mortality.</p></div><div><h3>Conclusions</h3><p>There appears to be no patient subgroup in whom the results of surgical resection were superior or comparable to those of transplantation. Tumor burden determination could be a useful tool for patient subclassification and help guide therapeutic decision-making.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 323-331"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000392/pdfft?md5=ccfbfbb8ad720031933157b65cff1b4c&pid=1-s2.0-S2255534X24000392-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141094783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Jejunal perforation associated with immune reconstitution inflammatory syndrome due to cytomegalovirus: A case report 巨细胞病毒引起的免疫重建炎症综合征伴有空肠穿孔:病例报告。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.04.007
{"title":"Jejunal perforation associated with immune reconstitution inflammatory syndrome due to cytomegalovirus: A case report","authors":"","doi":"10.1016/j.rgmxen.2024.04.007","DOIUrl":"10.1016/j.rgmxen.2024.04.007","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 457-459"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000604/pdfft?md5=7a32bb3d97b32c55c71bc01b2d2aa1b8&pid=1-s2.0-S2255534X24000604-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The string sign in Crohn’s disease 克罗恩病的弦征。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.04.004
{"title":"The string sign in Crohn’s disease","authors":"","doi":"10.1016/j.rgmxen.2024.04.004","DOIUrl":"10.1016/j.rgmxen.2024.04.004","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 447-448"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000562/pdfft?md5=86eeea4ff29179f2db577bf018e01cbc&pid=1-s2.0-S2255534X24000562-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute liver failure: Management update and prognosis 急性肝衰竭:管理更新和预后。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.05.002
L.M. Martínez-Martínez , G. Rosales-Sotomayor , E.A. Jasso-Baltazar , J.A. Torres-Díaz , D. Aguirre-Villarreal , I. Hurtado-Díaz de León , V.M. Páez-Zayas , A. Sánchez-Cedillo , S.E. Martínez-Vázquez , H.N. Tadeo-Espinoza , J.P. Guerrero-Cabrera , M. García-Alanis , I. García-Juárez

Acute liver failure is a rare but serious syndrome, with an incidence of approximately 2,000 to 3,000 cases per year in North America. Its pathophysiology and clinical course vary, depending on the cause of the primary liver injury, and can lead to high morbidity and mortality or the need for liver transplantation, despite available therapies. This syndrome involves excessive activation of the immune system, with damage in other organs, contributing to its high mortality rate. The most accepted definition includes liver injury with hepatic encephalopathy and coagulopathy within the past 26 weeks in a patient with no previous liver disease. The main causes are paracetamol poisoning, viral hepatitis, and drug-induced liver injury, among others. Identifying the cause is crucial, given that it influences prognosis and treatment. Survival has improved with supportive measures, intensive therapy, complication prevention, and the use of medications, such as N-acetylcysteine. Liver transplantation is a curative option for nonresponders to medical treatment, but adequate evaluation of transplantation timing is vital for improving results. Factors such as patient age, underlying cause, and severity of organ failure influence the post-transplant outcomes and survival.

急性肝衰竭是一种罕见但严重的综合征,在北美每年的发病率约为 2,000 到 3,000 例。其病理生理学和临床过程因原发性肝损伤的病因而异,可导致高发病率和死亡率,或尽管有可用的疗法,但仍需要进行肝移植。该综合征涉及免疫系统的过度激活,并伴有其他器官的损伤,因此死亡率很高。最广为接受的定义是,既往无肝病的患者在过去 26 周内出现肝损伤、肝性脑病和凝血功能障碍。主要病因包括扑热息痛中毒、病毒性肝炎和药物性肝损伤等。查明病因至关重要,因为它影响预后和治疗。通过支持性措施、强化治疗、并发症预防以及使用 N-乙酰半胱氨酸等药物,患者的生存率有所提高。对于药物治疗无效的患者,肝移植是一种治愈选择,但充分评估移植时机对提高疗效至关重要。患者的年龄、潜在病因和器官衰竭的严重程度等因素都会影响移植后的疗效和存活率。
{"title":"Acute liver failure: Management update and prognosis","authors":"L.M. Martínez-Martínez ,&nbsp;G. Rosales-Sotomayor ,&nbsp;E.A. Jasso-Baltazar ,&nbsp;J.A. Torres-Díaz ,&nbsp;D. Aguirre-Villarreal ,&nbsp;I. Hurtado-Díaz de León ,&nbsp;V.M. Páez-Zayas ,&nbsp;A. Sánchez-Cedillo ,&nbsp;S.E. Martínez-Vázquez ,&nbsp;H.N. Tadeo-Espinoza ,&nbsp;J.P. Guerrero-Cabrera ,&nbsp;M. García-Alanis ,&nbsp;I. García-Juárez","doi":"10.1016/j.rgmxen.2024.05.002","DOIUrl":"10.1016/j.rgmxen.2024.05.002","url":null,"abstract":"<div><p>Acute liver failure is a rare but serious syndrome, with an incidence of approximately 2,000 to 3,000 cases per year in North America. Its pathophysiology and clinical course vary, depending on the cause of the primary liver injury, and can lead to high morbidity and mortality or the need for liver transplantation, despite available therapies. This syndrome involves excessive activation of the immune system, with damage in other organs, contributing to its high mortality rate. The most accepted definition includes liver injury with hepatic encephalopathy and coagulopathy within the past 26 weeks in a patient with no previous liver disease. The main causes are paracetamol poisoning, viral hepatitis, and drug-induced liver injury, among others. Identifying the cause is crucial, given that it influences prognosis and treatment. Survival has improved with supportive measures, intensive therapy, complication prevention, and the use of medications, such as N-acetylcysteine. Liver transplantation is a curative option for nonresponders to medical treatment, but adequate evaluation of transplantation timing is vital for improving results. Factors such as patient age, underlying cause, and severity of organ failure influence the post-transplant outcomes and survival.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 404-417"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000628/pdfft?md5=c8db886ea379421ed12b38f3a466c347&pid=1-s2.0-S2255534X24000628-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cyclic vomiting syndrome: From pathophysiology to treatment 周期性呕吐综合征:从病理生理学到治疗。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.06.001
R.A. Jiménez-Castillo , R. Frazier , T. Venkatesan , J.M. Remes-Troche

Cyclic vomiting syndrome (CVS) is a disorder characterized by recurrent and unpredictable episodes of intense vomiting, interspersed with periods of apparent wellbeing. This disorder, which primarily affects children and adolescents but can persist into adulthood, has recently been the subject of extensive study and analysis in the medical literature. The aim of the present review is to examine the most important aspects of the epidemiology, pathophysiology, subtypes, diagnostic criteria, and current management of CVS. Even though the exact etiology remains unknown, genetic factors (polymorphisms), nervous system alterations and autonomic dysregulation, and environmental factors (use and abuse of cannabinoids) are postulated as possible triggers. CVS has significant diagnostic challenges, given that there is no specific test for confirming its presence. Thorough evaluation of symptoms and the ruling out of other possible causes of recurrent vomiting are required. Management of CVS typically involves a multidisciplinary approach. Pharmacologic options are explored, such as antiemetics and preventive medications, as well as behavioral and psychologic support therapies. Treatment personalization is essential, adapting it to the individual needs of each patient. Despite advances in the understanding of CVS, it remains a significant clinical challenge. This disorder impacts the quality of life of those affected and their families, underscoring the ongoing need for research and the development of more effective treatment strategies.

周期性呕吐综合征(CVS)是一种疾病,其特征是反复发作且无法预测的剧烈呕吐,其间夹杂着明显的安宁期。这种疾病主要影响儿童和青少年,但也可能持续到成年,最近医学文献对其进行了广泛的研究和分析。本综述旨在研究 CVS 的流行病学、病理生理学、亚型、诊断标准和当前管理等最重要的方面。尽管确切的病因尚不清楚,但遗传因素(多态性)、神经系统改变和自律神经失调以及环境因素(使用和滥用大麻素)被推测为可能的诱因。CVS 在诊断方面有很大的挑战,因为目前还没有特异性的检测方法来确认它的存在。需要对症状进行彻底评估,并排除导致反复呕吐的其他可能原因。CVS 的治疗通常涉及多学科方法。可选择药物治疗,如止吐药和预防性药物,以及行为和心理支持疗法。根据每位患者的不同需求进行个性化治疗至关重要。尽管人们对 CVS 的认识有所进步,但它仍然是一项重大的临床挑战。这种疾病影响着患者及其家人的生活质量,因此需要不断研究和开发更有效的治疗策略。
{"title":"Cyclic vomiting syndrome: From pathophysiology to treatment","authors":"R.A. Jiménez-Castillo ,&nbsp;R. Frazier ,&nbsp;T. Venkatesan ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmxen.2024.06.001","DOIUrl":"10.1016/j.rgmxen.2024.06.001","url":null,"abstract":"<div><p>Cyclic vomiting syndrome (CVS) is a disorder characterized by recurrent and unpredictable episodes of intense vomiting, interspersed with periods of apparent wellbeing. This disorder, which primarily affects children and adolescents but can persist into adulthood, has recently been the subject of extensive study and analysis in the medical literature. The aim of the present review is to examine the most important aspects of the epidemiology, pathophysiology, subtypes, diagnostic criteria, and current management of CVS. Even though the exact etiology remains unknown, genetic factors (polymorphisms), nervous system alterations and autonomic dysregulation, and environmental factors (use and abuse of cannabinoids) are postulated as possible triggers. CVS has significant diagnostic challenges, given that there is no specific test for confirming its presence. Thorough evaluation of symptoms and the ruling out of other possible causes of recurrent vomiting are required. Management of CVS typically involves a multidisciplinary approach. Pharmacologic options are explored, such as antiemetics and preventive medications, as well as behavioral and psychologic support therapies. Treatment personalization is essential, adapting it to the individual needs of each patient. Despite advances in the understanding of CVS, it remains a significant clinical challenge. This disorder impacts the quality of life of those affected and their families, underscoring the ongoing need for research and the development of more effective treatment strategies.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 389-403"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000616/pdfft?md5=bbb72d6aa141ff7bff490e20bc845ef7&pid=1-s2.0-S2255534X24000616-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SOX9 immunosuppression in primary colorectal cancer tumors with lymph node metastasis 伴有淋巴结转移的原发性结直肠癌肿瘤中的 SOX9 免疫抑制。
Pub Date : 2024-07-01 DOI: 10.1016/j.rgmxen.2024.01.004

Introduction and aims

Colorectal cancer is the most frequent malignant tumor of the digestive system. Its pathogeny is complex and involves the APC/β-catenin sequence. Lymph node metastases are a significant indicator for determining treatment and are a prognostic factor. SOX9 overexpression is related to oncogenic qualities and the capacity for metastasis. Our aim was to analyze SOX9 immunoexpression in primary colorectal cancer and lymph node metastasis status.

Material and methods

Seventy-nine available cases were divided into the group with lymph node metastasis (n = 38) and the group without lymph node metastasis (n = 41), evaluating their SOX9 expression. The IBM SPSS version 27 program in Spanish was utilized to carry out the statistical analysis, obtaining measures of central tendency, the kappa index, standard deviation, Wilcoxon Mann-Whitney nonparametric measurements, Spearman’s correlation coefficient, and chi-square test and Student’s t test values. SOX9 immunoexpression was evaluated through the mean-based H-score, with high immunoexpression as a score ≥145 and low immunoexpression as a score ≤144.

Results

A p = 0.73 was obtained that was not statistically significant, regarding the relation of SOX9 expression in primary colorectal cancer to lymph node metastasis.

Conclusions

The absence or presence of lymph node metastasis was independent from SOX9 immunoexpression in primary colorectal cancer. However, due to the limited size of the population analyzed, further research is needed.

导言和目的:结直肠癌是消化系统中最常见的恶性肿瘤。其病因复杂,涉及 APC/β-catenin 序列。淋巴结转移是决定治疗的重要指标,也是预后因素之一。SOX9的过表达与致癌特性和转移能力有关。我们的目的是分析原发性结直肠癌中SOX9的免疫表达和淋巴结转移状况:将79例病例分为有淋巴结转移组(38例)和无淋巴结转移组(41例),评估其SOX9表达情况。采用 IBM SPSS 27 版西班牙语程序进行统计分析,得出中心倾向、卡帕指数、标准差、Wilcoxon Mann-Whitney 非参数测量、斯皮尔曼相关系数、卡方检验和学生 t 检验值。SOX9免疫表达通过基于平均值的H-评分进行评估,得分≥145分为高免疫表达,得分≤144分为低免疫表达:原发性结直肠癌中SOX9表达与淋巴结转移的关系P=0.73,无统计学意义:结论:原发性结直肠癌淋巴结转移与否与 SOX9 免疫表达无关。然而,由于分析的人群规模有限,还需要进一步研究。
{"title":"SOX9 immunosuppression in primary colorectal cancer tumors with lymph node metastasis","authors":"","doi":"10.1016/j.rgmxen.2024.01.004","DOIUrl":"10.1016/j.rgmxen.2024.01.004","url":null,"abstract":"<div><h3>Introduction and aims</h3><p>Colorectal cancer is the most frequent malignant tumor of the digestive system. Its pathogeny is complex and involves the APC/β-catenin sequence. Lymph node metastases are a significant indicator for determining treatment and are a prognostic factor. SOX9 overexpression is related to oncogenic qualities and the capacity for metastasis. Our aim was to analyze SOX9 immunoexpression in primary colorectal cancer and lymph node metastasis status.</p></div><div><h3>Material and methods</h3><p>Seventy-nine available cases were divided into the group with lymph node metastasis (n<!--> <!-->=<!--> <!-->38) and the group without lymph node metastasis (n<!--> <!-->=<!--> <!-->41), evaluating their SOX9 expression. The IBM SPSS version 27 program in Spanish was utilized to carry out the statistical analysis, obtaining measures of central tendency, the kappa index, standard deviation, Wilcoxon Mann-Whitney nonparametric measurements, Spearman’s correlation coefficient, and chi-square test and Student’s t test values. SOX9 immunoexpression was evaluated through the mean-based H-score, with high immunoexpression as a score ≥145 and low immunoexpression as a score ≤144.</p></div><div><h3>Results</h3><p>A p<!--> <!-->=<!--> <!-->0.73 was obtained that was not statistically significant, regarding the relation of SOX9 expression in primary colorectal cancer to lymph node metastasis.</p></div><div><h3>Conclusions</h3><p>The absence or presence of lymph node metastasis was independent from SOX9 immunoexpression in primary colorectal cancer. However, due to the limited size of the population analyzed, further research is needed.</p></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 3","pages":"Pages 369-378"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2255534X24000501/pdfft?md5=614f03d8239e6fad3a67e5fc13c01ec0&pid=1-s2.0-S2255534X24000501-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia de Mexico (English)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1